Literature DB >> 33500476

Motor cortical excitability predicts cognitive phenotypes in amyotrophic lateral sclerosis.

Smriti Agarwal1,2, Elizabeth Highton-Williamson3, Jashelle Caga3, James Howells3, Thanuja Dharmadasa3, José M Matamala3, Yan Ma3, Kazumoto Shibuya3, John R Hodges3, Rebekah M Ahmed3,4, Steve Vucic3, Matthew C Kiernan3,4.   

Abstract

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are well-recognised as an extended disease spectrum. This study hypothesised that cortical hyperexcitability, an early pathophysiological abnormality in ALS, would distinguish cognitive phenotypes, as a surrogate marker of pathological disease burden. 61 patients with ALS, matched for disease duration (pure motor ALS, n = 39; ALS with coexistent FTD, ALS-FTD, n = 12; ALS with cognitive/behavioural abnormalities not meeting FTD criteria, ALS-Cog, n = 10) and 30 age-matched healthy controls. Cognitive function on the Addenbrooke's cognitive examination (ACE) scale, behavioural function on the motor neuron disease behavior scale (MiND-B) and cortical excitability using transcranial magnetic stimulation (TMS) were documented. Cortical resting motor threshold (RMT), lower threshold indicating hyperexcitability, was lower in ALS-FTD (50.2 ± 6.9) compared to controls (64.3 ± 12.6, p < 0.005), while ALS-Cog (63.3 ± 12.7) and ALS (60.8 ± 13.9, not significant) were similar to controls. Short interval intracortical inhibition (SICI) was reduced across all ALS groups compared to controls, indicating hyperexcitability. On receiver operating characteristic curve analysis, RMT differentiated ALS-FTD from ALS (area under the curve AUC = 0.745, p = 0.011). The present study has identified a distinct pattern of cortical excitability across cognitive phenotypes in ALS. As such, assessment of cortical physiology may provide more precise clinical prognostication in ALS.

Entities:  

Mesh:

Year:  2021        PMID: 33500476      PMCID: PMC7838179          DOI: 10.1038/s41598-021-81612-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


  42 in total

1.  Stages of pTDP-43 pathology in amyotrophic lateral sclerosis.

Authors:  Johannes Brettschneider; Kelly Del Tredici; Jon B Toledo; John L Robinson; David J Irwin; Murray Grossman; EunRan Suh; Vivianna M Van Deerlin; Elisabeth M Wood; Young Baek; Linda Kwong; Edward B Lee; Lauren Elman; Leo McCluskey; Lubin Fang; Simone Feldengut; Albert C Ludolph; Virginia M-Y Lee; Heiko Braak; John Q Trojanowski
Journal:  Ann Neurol       Date:  2013-06-19       Impact factor: 10.422

2.  Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

Review 3.  Amyotrophic lateral sclerosis.

Authors:  Matthew C Kiernan; Steve Vucic; Benjamin C Cheah; Martin R Turner; Andrew Eisen; Orla Hardiman; James R Burrell; Margaret C Zoing
Journal:  Lancet       Date:  2011-02-04       Impact factor: 79.321

4.  Amyotrophic lateral sclerosis affects cortical and subcortical activity underlying motor inhibition and action monitoring.

Authors:  Bahram Mohammadi; Katja Kollewe; David M Cole; Anja Fellbrich; Marcus Heldmann; Amir Samii; Reinhard Dengler; Susanne Petri; Thomas F Münte; Ulrike M Krämer
Journal:  Hum Brain Mapp       Date:  2015-04-24       Impact factor: 5.038

5.  Cortical atrophy in ALS is critically associated with neuropsychiatric and cognitive changes.

Authors:  Eneida Mioshi; Patricia Lillo; Belinda Yew; Sharpley Hsieh; Sharon Savage; John R Hodges; Matthew C Kiernan; Michael Hornberger
Journal:  Neurology       Date:  2013-02-20       Impact factor: 9.910

6.  Patterns of neuronal degeneration in the motor cortex of amyotrophic lateral sclerosis patients.

Authors:  K Nihei; A C McKee; N W Kowall
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes.

Authors:  Rachel H Tan; Jillian J Kril; Manaal Fatima; Andrew McGeachie; Heather McCann; Claire Shepherd; Shelley L Forrest; Andrew Affleck; John B J Kwok; John R Hodges; Matthew C Kiernan; Glenda M Halliday
Journal:  Brain       Date:  2015-07-31       Impact factor: 13.501

8.  Structural brain correlates of cognitive and behavioral impairment in MND.

Authors:  Federica Agosta; Pilar M Ferraro; Nilo Riva; Edoardo G Spinelli; Adriano Chiò; Elisa Canu; Paola Valsasina; Christian Lunetta; Sandro Iannaccone; Massimiliano Copetti; Evelina Prudente; Giancarlo Comi; Andrea Falini; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2016-02-02       Impact factor: 5.038

9.  Apical dendrite degeneration, a novel cellular pathology for Betz cells in ALS.

Authors:  Barış Genç; Javier H Jara; Amiko K B Lagrimas; Peter Pytel; Raymond P Roos; M Marsel Mesulam; Changiz Geula; Eileen H Bigio; P Hande Özdinler
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379

10.  Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.

Authors:  Rachel H Tan; Yue Yang; Woojin S Kim; Carol Dobson-Stone; John B Kwok; Matthew C Kiernan; Glenda M Halliday
Journal:  Acta Neuropathol Commun       Date:  2017-10-27       Impact factor: 7.801

View more
  3 in total

Review 1.  Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis.

Authors:  Stephen A Goutman; Orla Hardiman; Ammar Al-Chalabi; Adriano Chió; Masha G Savelieff; Matthew C Kiernan; Eva L Feldman
Journal:  Lancet Neurol       Date:  2022-03-22       Impact factor: 59.935

Review 2.  Emerging Mechanisms Underpinning Neurophysiological Impairments in C9ORF72 Repeat Expansion-Mediated Amyotrophic Lateral Sclerosis/Frontotemporal Dementia.

Authors:  Iris-Stefania Pasniceanu; Manpreet Singh Atwal; Cleide Dos Santos Souza; Laura Ferraiuolo; Matthew R Livesey
Journal:  Front Cell Neurosci       Date:  2021-12-15       Impact factor: 5.505

Review 3.  Neuronal Hyperexcitability and Free Radical Toxicity in Amyotrophic Lateral Sclerosis: Established and Future Targets.

Authors:  Kazumoto Shibuya; Ryo Otani; Yo-Ichi Suzuki; Satoshi Kuwabara; Matthew C Kiernan
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.